News

EvokAI Creative Labs Initiates CE Mark Certification for Innovative Parkinson’s Disease Technology

VANCOUVER, BC / ACCESSWIRE / September 27, 2023 / EvokAI Creative Labs Inc. (TSXV:OKAI)(OTCQB:OKAIF) ("EvokAI" or the "Company"), a leading…

1 year ago

Avinger Raises $5.3 Million via At-The-Market Facility

Strengthens Balance Sheet in Support of Tigereye ST Launch and Coronary Product DevelopmentREDWOOD CITY, CA / ACCESSWIRE / September 27,…

1 year ago

Mentavi Health to Begin Screening for Binge Eating Disorders 

The leaders in online ADHD assessment and testing say studies show ​30% of ​people ​diagnosed ​with ADHD ​have disordered eating​GRAND…

1 year ago

Soundable Health Selected for Google for Startups Cloud Program

SAN FRANCISCO, CA / ACCESSWIRE / September 27, 2023 / Soundable Health, a health tech startup that offers innovative AI-based…

1 year ago

Theralase(R) Successfully Completes Non-GLP Toxicity Analysis for Brain Cancer

TORONTO, ON / ACCESSWIRE / September 27, 2023 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF) is a clinical…

1 year ago

CRISPR Therapeutics to Present at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting

ZUG, Switzerland and BOSTON, Sept. 27, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating…

1 year ago

Context Therapeutics Announces Acceptance of Abstract to be Presented at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting

PHILADELPHIA, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a biopharmaceutical company advancing…

1 year ago

Cytek® Biosciences Achieves ISO 13485 Certification at Headquarters

Certification Validates Company’s Commitment to Quality in all Areas, Helping to Advance Roadmap for Translational and Clinical Markets in the…

1 year ago

T-knife Therapeutics Announces Four Presentations at the Upcoming Society for Immunotherapy of Cancer (SITC) Annual Meeting

SAN FRANCISCO and BERLIN, Sept. 27, 2023 (GLOBE NEWSWIRE) -- T-knife Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to developing…

1 year ago

Scilex Holding Company Submits a Request to the Securities and Exchange Commission to Withdraw its Registration Statement on Form S-1 (File No. 333-271401)

PALO ALTO, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating…

1 year ago